Released Mar 17, 2015, after the close
10-Q filed Mar 17, 2015, 45 days after period end · 0001354488-15-001187
Q1 2015 · 10-Q
Revenue—
Net Income$288.39K$288.39K −56.4% vs Q1 2014−65.1% vs Q4 2014
EPS Diluted$0.01$0.01 −57.1% vs Q1 2014no prior Q4 2014 on file
Gross Profit$1,705,312−28.1%
Operating Income$328,444−60.3%
Operating Cash Flow$117,627−93.3%
Free Cash Flowderived$82,189−95.3%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2015 | Q1 2014 | Q1 2013 | Q1 2012 |
|---|---|---|---|---|
| Net Income | $288.39K | $661.93K | $1.05M | $1.15M |
| EPS Diluted | $0.01 | $0.03 | $0.05 | $0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pharma-Bio Serv, Inc. · CIK 1304161 · Engraved from SEC EDGAR